The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice.

Authors

Xiaoliang Jiang
Huadong Li
Yong Liu
Linlin Bao
Lingjun Zhan
Hong Gao
Wei Deng
Jing Xue
Jiangning Liu
Xing Liu
Junli Li
Jie Wang
Shuang Wu
Mingzhe Yan
Wei Luo
Pedro A. Jose, George Washington University
Chuan Qin
Xiuhong Yang
Dingyu Zhang
Zhiwei Yang

Document Type

Journal Article

Publication Date

1-1-2022

Journal

Journal of Cardiovascular Translational Research

Inclusive Pages

1-11

DOI

10.1007/s12265-021-10147-3

Comments

Online ahead of print

APA Citation

Jiang, X., Li, H., Liu, Y., Bao, L., Zhan, L., Gao, H., Deng, W., Xue, J., Liu, J., Liu, X., Li, J., Wang, J., Wu, S., Yan, M., Luo, W., Jose, P. A., Qin, C., Yang, X., Zhang, D., & Yang, Z. (2022). The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice.. Journal of Cardiovascular Translational Research, (). http://dx.doi.org/10.1007/s12265-021-10147-3

Peer Reviewed

1